Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

10.0%

1 terminated out of 10 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

80%

4 of 5 completed with results

Key Signals

4 with results83% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (10)

Trial Status

Completed5
Recruiting2
Active Not Recruiting1
Not Yet Recruiting1
Terminated1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (10)

Research Network

Activity Timeline